NanoString Technologies Inc (NSTG) reported quarterly earnings results on Thursday, May-5-2016. The company reported $-0.74 earnings per share for the quarter, missing the analyst consensus estimate by $-0.08. Analysts had a consensus of $-0.66. The company posted revenue of $14.70 million in the period, compared to analysts expectations of $14.92 million. The company’s revenue was up 26.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.81 EPS.
NanoString Technologies Inc closed down -0.07 points or -0.43% at $16.19 with 1,11,686 shares getting traded on Wednesday. Post opening the session at $16.17, the shares hit an intraday low of $16.02 and an intraday high of $16.38 and the price fluctuated in this range throughout the day.Shares ended Wednesday session in Red.
In a different news, on Aug 14, 2015, Wayne Burns (SVP, Operations & Admin) sold 30,000 shares at $14.93 per share price. According to the SEC, on Aug 11, 2015, Barney Saunders (SVP, Sales & Marketing) sold 27,242 shares at $15.08 per share price.
NanoString Technologies Inc. is engaged in detection identification and quantification of individual target molecules in a biological sample by attaching a color coded fluorescent reporter to each target molecule of interest. The Company markets its nCounter Analysis System consisting of instruments and consumables including its Prosigna Breast Cancer Assay to academic government and biopharmaceutical and clinical laboratory customers. The Company’s nCounter Analysis System is an automated multi-application digital detection and counting system which directly profiles molecules using a barcoding technology. As of December 31 2014 the Company has an installed base of 264 systems. Prosigna the Company’s molecular diagnostic test is based on a collection of 50 genes known as the PAM50 gene signature.